IP Library Granted Patent US 10,238,850
Granted Patent B2
US 10,238,850 · App. 14/599,376 · Granted Mar 26, 2019

Systems and methods for radiographically identifying an access port

Inventors: Ketan K. Maniar (Mahwah, NJ); Sean M. Worthen (West Jordan, UT); Kelly B. Powers (North Salt Lake, UT)
Assignee: Bard Peripheral Vascular, Inc.
A61M39/0208A61B6/12A61M39/0247A61M2039/0205A61M2039/0211A61M2039/0238A61M2205/32A61M2205/582A61M2205/6054A61M2207/00Y10T156/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,238,850
App. No.
14/599,376
Granted
Mar 26, 2019
Kind
B2
Abstract

An access port for subcutaneous implantation is disclosed. Such an access port may comprise a body for capturing a septum for repeatedly inserting a needle therethrough into a cavity defined within the body. Further, the access port may include at least one feature structured and configured for identification of the access port subsequent to subcutaneous implantation. Methods of identifying a subcutaneously implanted access port are also disclosed. For example, a subcutaneously implanted access port may be provided and at least one feature of the subcutaneously implanted access port may be perceived. Further, the subcutaneously implanted access port may be identified in response to perceiving the at least one feature. In one embodiment, an identification feature is included on an insert that is incorporated into the access port so as to be visible after implantation via x-ray imaging technology.

Claims (28)

1. An access port for providing subcutaneous access to a patient, comprising:

a port body including:

a central region and a peripheral region surrounding the central region;

a fluid cavity located in the central region, the fluid cavity having a base surface lying in a first plane;

one or more recessed sections located in the peripheral region, at least one of the one or more recessed sections having a depth extending from a bottom surface of the peripheral region through the first plane;

an outlet stem in fluid communication with the fluid cavity;

a septum positioned over the fluid cavity; and

a radiopaque insert filling the one or more recessed sections.

2. The access port according to claim 1 , wherein the radiopaque insert comprises a pattern or an indicia for identification of an aspect or characteristic of the access port.

3. The access port according to claim 2 , wherein the radiopaque insert further comprises an identification feature that is observable via x-ray imaging technology subsequent to subcutaneous implantation of the access port in the patient, the identification feature identifying the access port as a power-injectable port.

4. The access port according to claim 3 , wherein the identification feature includes alphanumeric indicia.

5. The access port according to claim 4 , wherein the alphanumeric indicia includes letters “C” and “T”.

6. The access port according to claim 1 , wherein the radiopaque insert comprises an identification feature that is observable via x-ray imaging technology subsequent to subcutaneous implantation of the access port in the patient, the identification feature identifying the access port as a power-injectable port.

7. The access port according to claim 6 , wherein the identification feature includes alphanumeric indicia.

8. The access port according to claim 7 , wherein the alphanumeric indicia includes letters “C” and “T”.

9. The access port according to claim 1 , wherein the radiopaque insert is formed via injection molding.

10. The access port according to claim 1 , wherein the one or more recessed sections comprise a plurality of recessed sections.

11. The access port according to claim 10 , wherein a bottom surface of the radiopaque insert is substantially flush with a bottom surface of the central region.

12. The access port according to claim 1 , wherein the radiopaque insert is visible when viewing a bottom of the access port prior to implantation of the access port in the patient.

13. The access port according to claim 1 , wherein the radiopaque insert comprises a mixture including a metal oxide.

14. The access port according to claim 13 , wherein the mixture includes acetyl resin, and wherein the metal oxide is bismuth trioxide.

15. The access port according to claim 14 , wherein the mixture includes about 70 percent by weight acetyl resin and about 30 percent by weight bismuth trioxide.

16. A power injectable access port, comprising:

a port base including one or more fluid cavities, the one or more fluid cavities having a base surface lying in a first plane;

a port cap including a recessed region in a bottom surface, the recessed region surrounding the one or more fluid cavities and having a depth extending through the first plane, the recessed region defining a pattern or indicia indicating that the power injectable access port is suitable for power injection; and

at least one septum captured between the port cap and the port base.

17. The power injectable access port according to claim 16 , wherein the pattern or indicia includes alphanumeric indicia.

18. The power injectable access port according to claim 17 , wherein the alphanumeric indicia includes letters “C” and “T”.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2017
From: C. R. BARD, INC.
To: BARD PERIPHERAL VASCULAR, INC.
Reel/Frame 043129/0328 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2017
From: MANIAR, KETAN K.; WORTHEN, SEAN M.; POWERS, KELLY B.
To: C. R. BARD, INC.
Reel/Frame 043094/0771 →
Continuity (9)
Division 13776517 · Feb 25, 2013
Division 13250909 · Sep 30, 2011
Division 12796133 · Jun 8, 2010
Continuation In Part 12610084 · Oct 30, 2009
Continuation In Part 12420028 · Apr 7, 2009
Continuation In Part 11368954 · Mar 6, 2006
Provisional Application 60658518 · Mar 4, 2005
Provisional Application 61110507 · Oct 31, 2008
Related Publication 20150231383A1 · Aug 20, 2015
Cited By (1)
US 12,427,294